UBS Collaborates with Nobel Laureate Robert Engle on a New Volatility Controlled Index Series
Due to the information provided in the press release fragment, I can only summarize that UBS has announced a collaboration with Engle Volatility Consulting , led by Nobel Laureate Dr. Robert F. Engle, to develop a methodology for volatility-controlled indices. The initiative aims to create rules-based systematic investment strategies for enhanced exposure to various underlying assets.
In base alle informazioni fornite nel frammento del comunicato stampa, posso riassumere che UBS ha annunciato una collaborazione con Engle Volatility Consulting, guidata dal Premio Nobel Dr. Robert F. Engle, per sviluppare una metodologia per indici controllati dalla volatilità. L'iniziativa mira a creare strategie di investimento sistematiche basate su regole per un'esposizione migliorata a vari attivi sottostanti.
Según la información proporcionada en el fragmento del comunicado de prensa, solo puedo resumir que UBS ha anunciado una colaboración con Engle Volatility Consulting, dirigida por el Premio Nobel Dr. Robert F. Engle, para desarrollar una metodología para índices controlados por volatilidad. La iniciativa tiene como objetivo crear estrategias de inversión sistemáticas basadas en reglas para una mayor exposición a varios activos subyacentes.
보도 자료의 정보에 따르면, UBS는 노벨상 수상자인 로버트 F. 엥글 박사가 이끄는 Engle Volatility Consulting과 협력하여 변동성 제어 지수를 개발하는 방법론을 발표했다고 요약할 수 있습니다. 이 이니셔티브는 다양한 기초 자산에 대한 향상된 노출을 위한 규칙 기반의 체계적인 투자 전략을 만드는 것을 목표로 합니다.
En raison des informations fournies dans le fragment du communiqué de presse, je peux seulement résumer que UBS a annoncé une collaboration avec Engle Volatility Consulting, dirigée par le lauréat du prix Nobel, Dr. Robert F. Engle, pour développer une méthodologie pour les indices contrôlés par la volatilité. L'initiative vise à créer des stratégies d'investissement systématiques basées sur des règles pour une exposition améliorée à divers actifs sous-jacents.
Basierend auf den im Pressetext bereitgestellten Informationen kann ich zusammenfassen, dass UBS eine Zusammenarbeit mit Engle Volatility Consulting angekündigt hat, die von dem Nobelpreisträger Dr. Robert F. Engle geleitet wird, um eine Methodik für volatilitätskontrollierte Indizes zu entwickeln. Die Initiative zielt darauf ab, regelbasiierte systematische Anlagestrategien für eine verbesserte Exponierung gegenüber verschiedenen Basiswerten zu schaffen.
- Partnership with Nobel Laureate enhances UBS's credibility in volatility management
- Development of new systematic investment products expands UBS's offering portfolio
- None.
Insights
This collaboration between UBS and Nobel Laureate Robert Engle, while prestigious, falls into the category of a routine product development announcement without immediate material impact on UBS's financial performance or stock valuation. While Dr. Engle's expertise in volatility modeling and his Nobel Prize-winning research are significant academic achievements, the announcement lacks specific details about:
- Revenue projections or monetization strategy
- Implementation timeline
- Market demand or client commitments
- Competitive advantages over existing volatility-controlled products
The development of new index products is a regular occurrence in the financial services industry. Without concrete financial metrics or clear differentiation from existing products, this news is primarily focused on brand positioning and intellectual property development rather than immediate business impact.
The first of the index series will aim at improving the risk-return profile of major benchmark equity indices in order to serve the increasing demand in retirement products and help investors achieve their financial goals.
Ghali El-Boukfaoui, Head of Insurance Sales at UBS Investment Bank, said: “We are excited to collaborate with Dr. Engle to bring this innovation to the retirement market. Volatility control methodologies have, for the longest time, been overlooked from an innovation standpoint and we take the view that a good volatility forecasting method can lead to enhanced performance.”
El-Boukfaoui adds: “Dr. Engle has spent his career solving for the volatility forecasting problem as an indicator for price actions, and the goal of our collaboration is to bring an innovation that positively impacts the financial outcome of investors.”
“The heart of a good volatility-control mechanism is a good forecast of volatility,” said Dr. Robert Engle. These indices are designed to give investors exposure to benchmarks with a competitive risk-return profile by applying an innovative forward-looking intraday volatility control based on a volatility forecasting model.
The model is based on Dr. Engle's research and aims at producing a more reactive intraday allocation mechanism that can rapidly adapt to changing market conditions and more accurately predict volatility by using a variation of the ARCH model.
For more information please visit https://indices.ubs.com/engle
About UBS
UBS is a leading global asset manager and the leading universal bank in
Disclosures
This material is authorized for distribution only when accompanied or preceded by a prospectus and an applicable product brochure for the annuities being offered. The prospectus contains features, benefits, risks, fees, and other information regarding the registered index-linked annuity contract, which should be considered carefully before investing. You should read the prospectus carefully before investing money.
This material is for distribution only under such circumstances as may be permitted by applicable law. It has not been prepared with regard to the specific investment objectives, financial situation or particular needs of any specific recipient. It is published solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments or to participate in any particular trading strategy. Options, derivative products and futures are not suitable for all investors, and trading in these instruments is considered risky. The recipient should not construe the contents of this material as legal, tax, accounting, regulatory, or other specialist or technical advice or services or investment advice or a personal recommendation. Foreign currency rates of exchange may adversely affect the value, price or income of any security or related instrument mentioned in this material. No representation or warranty, either express or implied, is provided in relation to the accuracy, completeness or reliability of the information contained herein except with respect to information concerning UBS AG, its subsidiaries and affiliates ("UBS"), nor is it intended to be a complete statement or summary of the securities markets or developments referred to in this material or a guarantee that the services described herein comply with all applicable laws, rules and regulations. It should not be regarded by recipients as a substitute for the exercise of their own judgment. Any opinions expressed in this material are subject to change without notice and may differ or be contrary to opinions expressed by other business areas or groups of UBS as a result of using different assumptions and criteria. UBS is under no obligation to update or keep current the information contained herein, and past performance is not necessarily indicative of future results. UBS, its directors, officers, employees or clients may have or have had interest or long or short positions in the securities or other financial instruments referred to herein and may at any time make purchases and/or sales in them as principal or agent. UBS may act or have acted as market-maker in the securities or other financial instruments discussed in this material. Furthermore, UBS may have or have had a relationship with or may provide or have provided investment banking, capital markets and/or other financial services to the relevant companies. Neither UBS nor any of its directors, officers, employees or agents accepts any liability for any loss or damage arising out of the use of all or any part of this material or reliance upon any information contained herein. Additional information may be made available upon request. Not all products or services described herein are available in all jurisdictions and clients wishing to effect transactions should contact their local sales representative for further information and availability. © UBS 2025. All rights reserved.
Engle Consulting is not an investment adviser, does not guarantee the accuracy and completeness of any index in the index series described herein or any data or methodology either included therein or upon which it is based. The indices are not sponsored, endorsed, sold or promoted by Engle Consulting or Robert F. Engle. Engle Consulting and Robert F. Engle do not make any representation or warranty, express or implied, to any financial institution, investor of or counterparties to any index or to any member of the public regarding the advisability of investing in securities generally or in any of the indices.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250116840958/en/
Media
Tel. +1-212-713-2296
Source: UBS
FAQ
What is UBS's new volatility controlled index series collaboration about?
Who is partnering with UBS on their new volatility index series?
What is the purpose of UBS's new volatility controlled indices?
When did UBS announce their collaboration with Robert Engle?
